FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

A M E Claessen

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Bronchoalveolar Lavage Fluid

Procedures

Living Beings

Concepts & Ideas

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Physiology

Immunity, Mucosal

Co-author Network

Publications

TOP 3
Michiel Heron; D Hijdra; Henk Ruven; K M ten Dam-Molenkamp; J M M van den Bosch; A van Heugten-Roeling; A M E Claessen; Jan C Grutters; Heleen van Velzen-Blad
Bronchoalveolar lavage cell pattern from healthy human lung.
Daniëlle Hijdra; A M E Claessen; Jan C Grutters; Adriane Dm Vorselaars; Ger T Rijkers
Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes.
Michiel Heron; A M E Claessen; Jan C Grutters; Jules M M van den Bosch
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of A M E Claessen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michiel Heron; D Hijdra; Henk Ruven; K M ten Dam-Molenkamp; J M M van den Bosch; A van Heugten-Roeling; A M E Claessen; Jan C Grutters; Heleen van Velzen-Blad
Bronchoalveolar lavage cell pattern from healthy human lung.
Clinical and experimental immunology 2012;167(3):523-31.
2012: Daniëlle Hijdra; A M E Claessen; Jan C Grutters; Adriane Dm Vorselaars; Ger T Rijkers
Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes.
Journal of inflammation (London, England) 2012;9(1):38.
2010: Michiel Heron; A M E Claessen; Jan C Grutters; Jules M M van den Bosch
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?
Clinical and experimental immunology 2010;160(2):256-65.
2009: Michiel Heron; Jan C Grutters; C van moorsel; Henk Ruven; T W J Huizinga; A H M van der Helm-van Mil; A M E Claessen; Jules M M van den Bosch
Variation in IL7R predisposes to sarcoid inflammation.
Genes and immunity 2009;10(7):647-53.
2009: Michiel Heron; Jan C Grutters; C van moorsel; Henk Ruven; K M Kazemier; A M E Claessen; Jules M M van den Bosch
Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography.
Clinical immunology (Orlando, Fla.) 2009;133(1):117-25.
2007: Ankie M T van der Velden; A M E Claessen; Heleen van Velzen-Blad; M R de Groot; Mark H H Kramer; Douwe H Biesma; Ger T Rijkers
Vaccination responses and lymphocyte subsets after autologous stem cell transplantation.
Vaccine 2007;25(51):8512-7.
2007: M Veltkamp; Petal A H M Wijnen; C van moorsel; Ger T Rijkers; Henk Ruven; Michiel Heron; Otto Bekers; A M E Claessen; M Drent; Jules M M van den Bosch; Jan C Grutters
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.
Clinical and experimental immunology 2007;149(3):453-62.
2007: Ankie M T van der Velden; A M E Claessen; Heleen van Velzen-Blad; Douwe H Biesma; Ger T Rijkers
Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of gamma-interferon.
Bone marrow transplantation 2007;40(3):261-6.
2007: Michiel Heron; A M E Claessen; Jan C Grutters
Invariant natural killer T cells in obstructive pulmonary diseases.
The New England journal of medicine 2007;357(2):194; author reply 194-5.
2007: Ankie M T van der Velden; Heleen van Velzen-Blad; A M E Claessen; René van der Griend; Ruud Oltmans; Ger T Rijkers; Douwe H Biesma
The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia.
European journal of haematology 2007;79(1):47-52.
2005: Ankie M T van der Velden; A M E Claessen; Heleen van Velzen-Blad; Douwe H Biesma; Ger T Rijker
Development of functional Haemophilus influenzae type b antibodies after vaccination.
Haematologica 2005;90(11):1582-4.
2002: Arnold Baars; A M E Claessen; John Wagstaff; Giuseppe Giaccone; Rik J Scheper; Sybren Meijer; M J A G Schakel; Helen Gall; C J L M Meijer; Jan B Vermorken; HERBERT PINEDO; Alfons J M van den Eertwegh
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma.
British journal of cancer 2002;86(8):1230-4.
2000: Arnold Baars; A M E Claessen; Alfons J M van den Eertwegh; Helen Gall; Anita G M Stam; Sybren Meijer; Giuseppe Giaccone; Chris J L M Meijer; Rik J Scheper; John Wagstaff; Jan B Vermorken; HERBERT PINEDO
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):965-70.
1999: Jan B Vermorken; A M E Claessen; H van Tinteren; Helen Gall; R Ezinga; Sybren Meijer; Rik J Scheper; Chris J L M Meijer; Elisabeth Bloemena; J H Ransom; M G Hanna; HERBERT PINEDO
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
Lancet 1999;353(9150):345-50.
1997: WM Mulder; Peter L Stern; MJ Stukart; E de Windt; R M Butzelaar; Sybren Meijer; H J Adér; A M E Claessen; Jan B Vermorken; Chris J L M Meijer; John Wagstaff; Rik J Scheper; Elisabeth Bloemena
Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1923-30.
1997: Henk J Broxterman; Gerrit J Schuurhuis; Jan Lankelma; Jan W Oberink; CA Eekman; A M E Claessen; Klaas Hoekman; M Poot; HERBERT PINEDO
Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain.
British journal of cancer 1997;76(8):1029-34.
1996: Rik J Scheper; M E von Blomberg; J de Groot; D A Wolvers; Georg Kraal; A M E Claessen
Reversal of orally induced T-cell tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization.
Annals of the New York Academy of Sciences 1996;795():403-9.
1996: A M E Claessen; B Mary E von Blomberg; J De Groot; D A Wolvers; Georg Kraal; Rik J Scheper
Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization.
Immunology 1996;88(3):363-7.
1992: A M E Claessen; Elisabeth Bloemena; H Bril; Chris J L M Meijer; Rik J Scheper
Locoregional administration of etoposide, but not of interleukin 2, facilitates active specific immunization in guinea pigs with advanced carcinoma.
Cancer research 1992;52(9):2440-6.
1991: A M E Claessen; H Valster; H Bril; P A Steerenberg; B T Tan; Rik J Scheper
Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
International journal of cancer. Journal international du cancer 1991;47(4):626-32.
1989: A M E Claessen; H Valster; H Bril; S Meyer; Rik J Scheper
Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.
Cancer immunology, immunotherapy : CII 1989;28(2):131-5.
1987: R J Scheper; Jacqueline Limpens; B T Tan; H Valster; A M E Claessen; M E Claessen
Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.
Methods and findings in experimental and clinical pharmacology 1987;9(9):611-5.